COMP <GO>
HSAI vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY
Hesai Group (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: HSAI 3
— TMO 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
LAST: $12.97 (-6.22%) • MKT CAP: $2.04B
balance-sheet
4.21
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
balance-sheet
4.50
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSAI VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSAI | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 9.30% | -7.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.8x | 30.4x | -0.60 | HSAI | /valuation <GO> |
| Free Cash Flow Yield | -1.35% | 2.40% | -3.75 | TMO | /fcf-yield <GO> |
| Operating Margin | 5.60% | 17.40% | -11.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | 14.40% | 15.10% | -0.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 52.10% | 3.90% | +48.20 | HSAI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.21 | 4.50 | -0.29 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.9 | 62.9 | -25.98 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.5x | 36.3x | -8.80 | HSAI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.04B | $262.22B | -$260.18B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSAI REV | TMO REV | HSAI GROSS % | TMO GROSS % | HSAI FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $432.9M | $44.56B | 41.8% | — | -$27.5M | $6.29B |
| FY 2024 | $284.6M | $42.88B | 42.6% | — | -$26.9M | $7.27B |
| FY 2023 | $264.4M | $42.86B | — | — | $8.1M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSAI // BETA —
TMO // BETA 0.94